Abstract
It already exists within the US Food and Drug Administration, argues a former clinical reviewer of psychotropic drugs at the FDA
Keywords
TaxpayerMedicineClinical trialMEDLINEFamily medicineDatabaseComputer scienceInternal medicinePolitical science
Related Publications
2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials
This publication describes uniform definitions for cardiovascular and stroke outcomes developed by the Standardized Data Collection for Cardiovascular Trials Initiative and the ...
Small molecules in targeted cancer therapy: advances, challenges, and future perspectives
Due to the advantages in efficacy and safety compared with traditional chemotherapy drugs, targeted therapeutic drugs have become mainstream cancer treatments. Since the first t...
Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018
Importance The mean cost of developing a new drug has been the subject of debate, with recent estimates ranging from $314 million to $2.8 billion. Objective To estimate the rese...
Meta-analysis Spurious precision? Meta-analysis of observational studies
In previous articles we have focused on the potentials, principles, and pitfalls of meta-analysis of randomised controlled trials.1 2 3 4 5 Meta-analysis of observational data i...
Clinical End Points in Coronary Stent Trials
Background— Although most clinical trials of coronary stents have measured nominally identical safety and effectiveness end points, differences in definitions and timing of asse...
Publication Info
- Year
- 2004
- Type
- editorial
- Volume
- 1
- Issue
- 3
- Pages
- e60-e60
- Citations
- 55
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
55
OpenAlex
Cite This
Erick H. Turner
(2004).
A Taxpayer-Funded Clinical Trials Registry and Results Database.
PLoS Medicine
, 1
(3)
, e60-e60.
https://doi.org/10.1371/journal.pmed.0010060
Identifiers
- DOI
- 10.1371/journal.pmed.0010060